Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study

AIMS/INTRODUCTION: To investigate the efficacy/safety of dulaglutide once‐weekly monotherapy versus glimepiride in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: This was a post‐hoc analysis of a Chinese randomized, double‐blind, non‐inferiority, phase III study. Patients (n = 572) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Li Xin, Liu, Xiao Min, Shi, Yong Quan, Li, Quan Min, Ma, Jian Hua, Li, Yan Bing, Du, Li Ying, Wang, Feng, Chen, Lu Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944837/
https://www.ncbi.nlm.nih.gov/pubmed/31102326
http://dx.doi.org/10.1111/jdi.13075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944837/
https://www.ncbi.nlm.nih.gov/pubmed/31102326
http://dx.doi.org/10.1111/jdi.13075

Ejemplares similares